Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ronald Simon

Showing results (161-170 of 494) with videos related to

Pageof 50
Sort By:
EMBO Reports|September 7, 2016
Loss of CHD1 causes DNA repair defects and enhances prostate cancer therapeutic responsivenessVijayalakshmi Kari, Wael Yassin Mansour, Sanjay Kumar Raul, et al.
Pathology|May 5, 2010
Y chromosome loss is a frequent early event in urothelial bladder cancerSarah Minner, Adisa Kilgué, Phillip Stahl, et al.
World Journal of Urology|December 22, 2014
βIII-tubulin overexpression is linked to aggressive tumor features and shortened survival in clear cell renal cell carcinomaAlexander Quaas, Amir-Hossein Rahvar, Christoph Burdelski, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 3, 2008
Distinct subcellular expression patterns of neutral endopeptidase (CD10) in prostate cancer predict diverging clinical courses in surgically treated patientsAchim Fleischmann, Thorsten Schlomm, Hartwig Huland, et al.
The Journal of Clinical Investigation|October 4, 2011
SCRIB expression is deregulated in human prostate cancer, and its deficiency in mice promotes prostate neoplasiaHelen B Pearson, Pedro A Perez-Mancera, Lukas E Dow, et al.
Clinical Oral Investigations|July 23, 2016
CD151 expression is frequent but unrelated to clinical outcome in head and neck cancerJulie C Nienstedt, Alexander Gröbe, Patrick Lebok, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 3, 2022
Estrogen Receptor Alpha Gene Amplification Is an Independent Predictor of Long-Term Outcome in Postmenopausal Patients with Endocrine-Responsive Early Breast CancerChristian F Singer, , Frederik Holst, et al.
BMC Medical Genetics|July 6, 2010
Pitfalls in mutational testing and reporting of common KIT and PDGFRA mutations in gastrointestinal stromal tumorsSabine Merkelbach-Bruse, Wolfgang Dietmaier, Laszlo Füzesi, et al.
Human Pathology|March 10, 2009
HER-2 amplification is highly homogenous in gastric cancerAndreas H Marx, Lars Tharun, Johanna Muth, et al.
Genes, Chromosomes & Cancer|September 30, 2009
PPFIA1 and CCND1 are frequently coamplified in breast cancerAna-Maria Dancau, Laura Wuth, Marcel Waschow, et al.
Pageof 50

Showing results (161-170 of 494) with videos related to

Sort By:
Pageof 50
EMBO Reports|September 7, 2016
Loss of CHD1 causes DNA repair defects and enhances prostate cancer therapeutic responsivenessVijayalakshmi Kari, Wael Yassin Mansour, Sanjay Kumar Raul, et al.
Pathology|May 5, 2010
Y chromosome loss is a frequent early event in urothelial bladder cancerSarah Minner, Adisa Kilgué, Phillip Stahl, et al.
World Journal of Urology|December 22, 2014
βIII-tubulin overexpression is linked to aggressive tumor features and shortened survival in clear cell renal cell carcinomaAlexander Quaas, Amir-Hossein Rahvar, Christoph Burdelski, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 3, 2008
Distinct subcellular expression patterns of neutral endopeptidase (CD10) in prostate cancer predict diverging clinical courses in surgically treated patientsAchim Fleischmann, Thorsten Schlomm, Hartwig Huland, et al.
The Journal of Clinical Investigation|October 4, 2011
SCRIB expression is deregulated in human prostate cancer, and its deficiency in mice promotes prostate neoplasiaHelen B Pearson, Pedro A Perez-Mancera, Lukas E Dow, et al.
Clinical Oral Investigations|July 23, 2016
CD151 expression is frequent but unrelated to clinical outcome in head and neck cancerJulie C Nienstedt, Alexander Gröbe, Patrick Lebok, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 3, 2022
Estrogen Receptor Alpha Gene Amplification Is an Independent Predictor of Long-Term Outcome in Postmenopausal Patients with Endocrine-Responsive Early Breast CancerChristian F Singer, , Frederik Holst, et al.
BMC Medical Genetics|July 6, 2010
Pitfalls in mutational testing and reporting of common KIT and PDGFRA mutations in gastrointestinal stromal tumorsSabine Merkelbach-Bruse, Wolfgang Dietmaier, Laszlo Füzesi, et al.
Human Pathology|March 10, 2009
HER-2 amplification is highly homogenous in gastric cancerAndreas H Marx, Lars Tharun, Johanna Muth, et al.
Genes, Chromosomes & Cancer|September 30, 2009
PPFIA1 and CCND1 are frequently coamplified in breast cancerAna-Maria Dancau, Laura Wuth, Marcel Waschow, et al.
Pageof 50